Literature DB >> 14161752

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.

H KUTT, M WOLK, R SCHERMAN, F MCDOWELL.   

Abstract

Entities:  

Keywords:  BARBITURATES; DIPHENYLHYDANTOIN; DRUG TOLERANCE; GENETICS, HUMAN; METABOLISM; PHARMACOLOGY; PHENOLS; PHENYLALANINE; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1964        PMID: 14161752     DOI: 10.1212/wnl.14.6.542

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  33 in total

1.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

2.  Individual variability in response to haloperidol.

Authors:  A O Forsman
Journal:  Proc R Soc Med       Date:  1976

Review 3.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.

Authors:  H Kutt; S Louis
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  The hydroxylation of drugs- a pharmacogenetic problem?

Authors:  D A Evans
Journal:  Proc R Soc Med       Date:  1970-02

6.  Reaction of drugs with microsomal liver hydroxylase: its influence on drug action.

Authors:  H Remmer; R W Estabrook; J Schenkman; H Greim
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

7.  Pharmacokinetics of single and multiple doses of phenytoin in man.

Authors:  L Lund; G Alvan; A Berlin; B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

8.  The distribution of plasma phenytoin levels in epileptic patients.

Authors:  P T Lascelles; R S Kocen; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

9.  Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Authors:  N Barth; G Alván; O Borgå; F Sjöqvist
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

10.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.